Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

American Healthcare REIT (AHR) Change in Acquisitions & Divestments (2023 - 2025)

American Healthcare REIT (AHR) has disclosed Change in Acquisitions & Divestments for 3 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Acquisitions & Divestments fell 81.61% year-over-year to $1.2 million, compared with a TTM value of $10.8 million through Dec 2025, down 64.05%, and an annual FY2025 reading of $10.8 million, down 64.05% over the prior year.
  • Change in Acquisitions & Divestments was $1.2 million for Q4 2025 at American Healthcare REIT, down from $3.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $10.9 million in Q2 2024 and bottomed at $1.2 million in Q4 2025.
  • Average Change in Acquisitions & Divestments over 3 years is $5.2 million, with a median of $4.4 million recorded in 2024.
  • The sharpest move saw Change in Acquisitions & Divestments rose 4.0% in 2024, then tumbled 81.61% in 2025.
  • Year by year, Change in Acquisitions & Divestments stood at $6.1 million in 2023, then increased by 4.0% to $6.3 million in 2024, then crashed by 81.61% to $1.2 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for AHR at $1.2 million in Q4 2025, $3.0 million in Q3 2025, and $3.6 million in Q2 2025.